Editorial: Cellular dysfunction and death in diabetes (etio)pathology: Novel insights into molecular mechanisms and therapeutic targeting

Editorial: Cellular dysfunction and death in diabetes (etio)pathology: Novel insights into molecular mechanisms and therapeutic targeting

Bibliographic Details
Main Authors:	M. Markelic, S. Batirel, A. Stancic
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Endocrinology
Subjects:	diabetes diabetic complications ferroptosis islet amyloid polypeptide beta cell death
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1121518/full

Similar Items

Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
by: Andisheh Abedini, et al.
Published: (2016-05-01)

Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer’s disease: two triggers, one disease
by: Sofia Ferreira, et al.
Published: (2021-01-01)

Heterologous Expression of Immature Forms of Human Islet Amyloid Polypeptide in Yeast Triggers Intracellular Aggregation and Cytotoxicity
by: Ana F. Raimundo, et al.
Published: (2020-09-01)

Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity
by: Pascal Krotee, et al.
Published: (2017-01-01)

Chitosan Oligosaccharides Attenuate Amyloid Formation of hIAPP and Protect Pancreatic β-Cells from Cytotoxicity
by: Qin-Yu Meng, et al.
Published: (2020-03-01)

Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus
by: Adriana Sevcuka, et al.
Published: (2022-04-01)

Islet amyloid polypeptide does not suppress pancreatic cancer
by: Austin J. Taylor, et al.
Published: (2023-02-01)

Diabetes mellitus drug discovery: insights into targeting feline and human amylin with small molecules
by: Kendall B. E. Moore, et al.
Published: (2023-12-01)

Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01)

Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages
by: Gabriela Dumitrita Stanciu, et al.
Published: (2020-06-01)

Fibril elongation by human islet amyloid polypeptide is the main event linking aggregation to membrane damage
by: Barend O.W. Elenbaas, et al.
Published: (2023-01-01)

Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies
by: Brittany S. Bruggeman, et al.
Published: (2021-11-01)

Efficacy of IAPP suppression in mouse and human islets by GLP-1 analogue conjugated antisense oligonucleotide
by: Tatyana Gurlo, et al.
Published: (2023-02-01)

Diversity of pathophysiology in type 2 diabetes shown by islet pathology
by: Hiroki Mizukami, et al.
Published: (2022-01-01)

Pentapeptide Protects INS-1 Cells From hIAPP-Mediated Apoptosis by Enhancing Autophagy Through mTOR Pathway
by: Jianzhen Lin, et al.
Published: (2019-08-01)

Addition of exogenous sodium palmitate increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1 cells
by: Camilla Krizhanovskii, et al.
Published: (2017-07-01)

Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
by: Queenie Hui, et al.
Published: (2017-08-01)

The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
by: Mohammed Alrouji, et al.
Published: (2023-05-01)

Type 2 diabetes mellitus as a prion disease (literature review)
by: A.S. Filimonova, et al.
Published: (2022-02-01)

Ferroptosis as a potential new therapeutic target for diabetes and its complications
by: Qian Deng, et al.
Published: (2023-02-01)

Oligomannuronate prevents mitochondrial dysfunction induced by IAPP in RINm5F islet cells by inhibition of JNK activation and cell apoptosis
by: Xi Liu, et al.
Published: (2020-03-01)

Defining the ferroptotic phenotype of beta cells in type 1 diabetes and its inhibition as a potential antidiabetic strategy
by: Milica Markelic, et al.
Published: (2023-08-01)

Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
by: Taisei Tanaka, et al.
Published: (2021-10-01)

Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes
by: Anne-Cathrine S. Vogt, et al.
Published: (2021-11-01)

Studies on alpha-synuclein and islet amyloid polypeptide interaction
by: Ye Wang, et al.
Published: (2023-01-01)

Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus
by: Elisa S. Roesti, et al.
Published: (2020-03-01)

What is a β cell? – Chapter I in the Human Islet Research Network (HIRN) review series
by: Klaus H. Kaestner, et al.
Published: (2021-11-01)

Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells
by: Terenzio Congiu, et al.
Published: (2021-06-01)

Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
by: Jeong HR, et al.
Published: (2015-11-01)

The association of circulating amylin with β‐amyloid in familial Alzheimer's disease
by: Han Ly, et al.
Published: (2021-01-01)

Animal Models for Understanding the Mechanisms of Beta Cell Death during Type 2 Diabetes Pathogenesis
by: Brittney A. Covington, et al.
Published: (2024-02-01)

Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer’s Disease
by: Rohith N Thota, et al.
Published: (2020-04-01)

Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas
by: Diti Chatterjee Bhowmick, et al.
Published: (2022-02-01)

Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
by: Raliat O. Abioye, et al.
Published: (2021-05-01)

Electrochemical Assay of Human Islet Amyloid Polypeptide and Its Aggregation
by: Genxi Li, et al.
Published: (2008-09-01)

Peri-Transplant Inflammation and Long-Term Diabetes Outcomes Were Not Impacted by Either Etanercept or Alpha-1-Antitrypsin Treatment in Islet Autotransplant Recipients
by: Tasneem R. Abdel-Karim, et al.
Published: (2024-01-01)

Contribution of the 12–17 hydrophobic region of islet amyloid polypeptide in self-assembly and cytotoxicity
by: Mathilde Fortier, et al.
Published: (2022-10-01)

Growth Hormone-Releasing Hormone in Diabetes
by: Leonid Evsey Fridlyand, et al.
Published: (2016-10-01)

Protective effects of metformin on pancreatic β-cell ferroptosis in type 2 diabetes in vivo
by: Yue Sun, et al.
Published: (2023-12-01)

Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications
by: Xi-Ding Yang, et al.
Published: (2022-03-01)